Intervening to reduce the risk of future disability from multiple sclerosis: are we there yet?-Reference-Cited by-同舟云学术

Intervening to reduce the risk of future disability from multiple sclerosis: are we there yet?

Published:2017-01-12 Issue:10 Volume:127 Page:944-951
ISSN:0020-7454
Container-title:International Journal of Neuroscience
language:en
Short-container-title:International Journal of Neuroscience

Author:

Dahdaleh Maurice¹,Alroughani Raed²,Aljumah Mohammed³⁴,AlTahan Abdulrahman⁵,Alsharoqi Issa⁶,Bohlega Saeed A⁷,Daif Abdulkader⁸,Deleu Dirk⁹,Inshasi Jihad¹⁰,Karabudak Rana¹¹,Sahraian Mohammed A.¹²,Taha Karim¹³,Yammout Bassem I.¹⁴,Zakaria Magd¹⁵

Affiliation:

1. Department of Internal Medicine, Neurology Section, Arab Medical Center and Khalidi Hospital, Amman, Jordan

2. Division of Neurology, Amiri Hospital, Kuwait and Division of Neurology, Dasman Diabetes Institute, Kuwait City, Kuwait

3. King Abdullah International Medical Research Center, King Saud Ben Abdulaziz University for Health Sciences, NGHA, Riyadh, Saudi Arabia

4. KFMC, Ministry of Health, Riyadh, Saudi Arabia

5. Neurology Section, King Khalid University Hospital, King Saud University and Dallah Hospital, Riyadh, Saudi Arabia

6. Clinical Neurosciences Department, Salmaniya Medical Complex, Manama, Bahrain

7. Department of Neurosciences, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia

8. Neurology Division, King Khalid University Hospital, King Saud University, Riyadh, Saudi Arabia

9. Department of Neurology (Medicine), Hamad Medical Corporation, Doha, Qatar

10. Neurology Department, Rashid Hospital and Dubai Medical College, Dubai Health Authority, Dubai, United Arab Emirates

11. Department of Neurology, Neuroimmunology Unit, Hacettepe University Hospitals, Ankara, Turkey

12. MS Research Center, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran

13. Merck Serono Intercontinental Region, Dubai, United Arab Emirates

14. Multiple Sclerosis Center, American University of Beirut Medical Center, Beirut, Lebanon

15. Neuropsychiatric Department, Faculty of Medicine, Ain Shams University, Egypt

Publisher

Informa UK Limited

Subject

General Medicine,General Neuroscience

Link

https://www.tandfonline.com/doi/pdf/10.1080/00207454.2016.1277424

Reference76 articles.

1. Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria

2. Functional clinical outcomes in multiple sclerosis: Current status and future prospects

3. Time to secondary progression in patients with multiple sclerosis who were treated with first generation immunomodulating drugs

4. Clinical predictors of disease progression in multiple sclerosis patients with relapsing onset in a nation-wide cohort

5. Onset of progressive phase is an age-dependent clinical milestone in multiple sclerosis

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current knowledge on multiple sclerosis pathophysiology, disability progression assessment and treatment options, and the role of autologous hematopoietic stem cell transplantation;Autoimmunity Reviews;2024-02

2. Disease Progression in Multiple Sclerosis: A Literature Review Exploring Patient Perspectives;Patient Preference and Adherence;2021-01

3. Neuro-Immune Hemostasis: Homeostasis and Diseases in the Central Nervous System;Frontiers in Cellular Neuroscience;2018-11-26

4. Neuro-Coagulopathy: Blood Coagulation Factors in Central Nervous System Diseases;International Journal of Molecular Sciences;2017-10-12